Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $502.15 ($4.8M) on 2026-09-14, disclosed to the SEC on 2026-09-15.
Scheduled sale ($4.8M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $502.15 | 1,580 | $793K | 16.6% |
| 2 | $503.44 | 2,358 | $1.2M | 24.8% |
| 3 | $504.47 | 2,722 | $1.4M | 28.7% |
| 4 | $505.25 | 2,400 | $1.2M | 25.3% |
| 5 | $506.48 | 440 | $223K | 4.7% |
| Total | $504.12 avg | 9,500 |
| $4.8M |
| 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |